Amtech Esters IPO Closes Today: Check GMP, Subscription, Price, Lot Size, Financials and IPO Review

Amtech Esters IPO Overview

Amtech Esters IPO is in its final day of subscription today, September 11, 2026. The SME public issue opened on September 9 with a price band of ₹71 to ₹75 per share and is being offered through the BSE SME platform.

The company is looking to raise approximately ₹17.88 crore through a fresh issue of 23.84 lakh equity shares. Since this is a fresh issue, the proceeds will go to Amtech Esters for its stated business and financial requirements.

The company operates in the specialty chemicals segment and has a product portfolio led by unsaturated polyester resins and related chemicals. Its business is also supported by its wholly owned subsidiary, Croda Pigments Private Limited.

Amtech Esters IPO Details

At the upper price of ₹75, one lot is worth ₹1.20 lakh. Retail investors need to apply for a minimum of two lots, making the minimum retail investment ₹2.40 lakh.

Amtech Esters IPO GMP Today

The latest available grey-market indication shows an Amtech Esters IPO GMP of around ₹11 per share.

At the upper price band of ₹75, this indicates an estimated grey-market price of approximately ₹86 per share, representing an indicative premium of about 14.67%.

The GMP has improved from around ₹6–₹7 earlier in the IPO period to approximately ₹11. However, GMP is an unofficial and unregulated indicator and the actual listing price can be very different.

Amtech Esters IPO Subscription Status

The IPO has attracted stronger demand as the bidding period has progressed.

The latest available data shows overall subscription of around 2.69x, with retail investors subscribing around 3.58x and NII participation at approximately 2.83x. QIB subscription stands at around 1x in the latest available data.

The subscription figures may continue changing until the issue closes today. Final exchange figures should be considered when assessing the completed IPO demand.

Amtech Esters IPO Lot Size and Investment

The IPO lot size is 1,600 shares. Because the minimum retail application is two lots, retail investors need to apply for 3,200 shares.

The ₹2.40 lakh minimum investment is an important consideration because SME IPO application requirements can be significantly higher than those of Mainboard issues.

Amtech Esters IPO Important Dates

The IPO closes on September 11, 2026. The tentative allotment is scheduled for September 15, followed by refunds and demat credit on September 16. The shares are expected to list on BSE SME on September 17.

About Amtech Esters

Amtech Esters was originally incorporated as Amtech Esters Private Limited in 2002. The company operates in the specialty chemicals industry and manufactures products used in industrial applications.

Its key product category is unsaturated polyester resin, which is used in applications involving composite materials, construction-related products and other industrial components.

The company has developed a broader portfolio of complementary chemicals and operates through its own manufacturing activities as well as its subsidiary structure.

Amtech Esters Product Portfolio

The company's business is centered around unsaturated polyester resins and complementary chemical products.

Unsaturated polyester resin is an important industrial material used in applications such as fiberglass-reinforced products, pipes, tanks, automotive components, construction materials and other composite products.

The company also has an integrated business relationship with its wholly owned subsidiary Croda Pigments Private Limited, which is expected to play an important role in the company's future expansion plans.

A broader product portfolio can help Amtech Esters serve different industrial customers, although revenue concentration in its major product categories remains an important risk.

Amtech Esters Expansion Plans

One of the major growth initiatives connected with the IPO is the planned expansion of the company's business through its subsidiary.

The company intends to invest part of the IPO proceeds into Croda Pigments Private Limited, including funding capital expenditure and working-capital requirements.

The company also plans to establish a new manufacturing facility at Asoda, Haryana. This expansion is expected to increase its production capabilities and provide room for future growth.

Amtech Esters IPO Objects of the Issue

The ₹17.88 crore raised through the IPO will be used for several purposes.

The largest identified portion is the investment in the wholly owned subsidiary. The company also intends to reduce borrowings, which could help lower financial costs and strengthen its balance sheet.

Amtech Esters Financial Performance

Amtech Esters has shown growth in sales over the reported period, although its profitability has been comparatively modest.

According to available financial data, sales increased from around ₹22.33 crore in FY2024 to ₹30.06 crore in FY2025. Total income increased to approximately ₹30.12 crore in FY2025.

However, profit after tax declined from ₹2.56 crore in FY2024 to around ₹1.97 crore in FY2025.

This combination of higher sales but lower profit is something investors should monitor carefully.

Amtech Esters Profitability

The company's operating profit improved from approximately ₹1.04 crore in FY2024 to ₹3.29 crore in FY2025.

However, after depreciation, interest and taxes, reported PAT declined to ₹1.97 crore in FY2025 from ₹2.56 crore in FY2024.

This indicates that the company has been growing its operating scale but needs to improve the conversion of revenue growth into consistent bottom-line growth.

Future profitability will depend on capacity utilisation, product margins, raw-material costs and the performance of the expanded business.

Amtech Esters IPO Business Strengths

Established operating history: The company has been operating since 2002 and has experience in specialty chemicals.

Product portfolio: Amtech Esters offers unsaturated polyester resins and related chemicals for industrial customers.

Expansion opportunity: The planned Asoda facility could provide additional production capacity.

Subsidiary integration: Croda Pigments provides another avenue for expanding the company's product and manufacturing base.

Debt reduction: A portion of IPO proceeds will be used for repayment or prepayment of borrowings.

Growing sales: FY2025 sales were higher than FY2024, showing an increase in business scale.

Amtech Esters IPO Risks

Investors should also consider the risks associated with the company and its SME listing.

Product concentration: A significant portion of the company's revenue is linked to unsaturated polyester resins, which creates product-concentration risk.

Single-region concentration: A substantial part of the company's operations is concentrated in Haryana, which could increase operational risk.

Raw-material volatility: Chemical manufacturing margins can be affected by fluctuations in the cost and availability of key raw materials.

Environmental regulations: Chemical manufacturing is subject to environmental, safety and regulatory requirements. Non-compliance or changes in regulations could increase costs.

Expansion execution: The expected benefits from the new Asoda facility depend on timely completion, successful commissioning and sufficient customer demand.

Profitability fluctuations: Despite sales growth, FY2025 PAT declined from the previous year, so sustained profit growth remains an important watchpoint.

SME liquidity: After listing, trading liquidity may be lower than that of larger Mainboard companies.

Amtech Esters IPO Valuation

At the upper price of ₹75, the company is being valued at a level that investors should compare with its earnings, book value and future expansion potential.

The FY2025 reported PAT of approximately ₹1.97 crore means investors should pay close attention to the relationship between the IPO valuation and the company's current earnings capacity.

The valuation case therefore depends partly on whether the company's planned capacity expansion can translate into stronger revenue and profitability in future years.

Amtech Esters IPO Review

Amtech Esters IPO presents a small specialty-chemical company with an established operating history, a focused product portfolio and plans to expand through its subsidiary.

The positive side of the story is the company's growing sales, planned capacity expansion, debt-reduction plans and increasing subscription demand. The latest GMP of around ₹11 also indicates a positive grey-market sentiment ahead of the proposed listing.

At the same time, the financial history requires a closer look. Revenue has increased, but FY2025 profit declined compared with FY2024. The business also faces raw-material, environmental, product-concentration and expansion-execution risks.

For short-term IPO investors, the current GMP and subscription figures may remain important. For longer-term investors, the key question will be whether the new capacity and subsidiary investment can produce sustainable growth in earnings.

What Investors Should Watch

After listing, investors should track the following factors:

• Capacity utilisation at the new facility.
• Revenue growth from unsaturated polyester resins.
• Performance of Croda Pigments.
• Raw-material costs.
• Operating margins.
• Interest expenses after debt repayment.
• Cash-flow generation.
• Customer concentration.
• Progress of the Asoda manufacturing facility.
• Profit growth after expansion.

These indicators can help determine whether the IPO's growth expectations are being converted into actual business performance.

Amtech Esters IPO Key Highlights

*GMP and subscription figures are unofficial/live-market indicators and can change during the IPO.

Conclusion

Amtech Esters IPO is a ₹17.88 crore SME issue focused on raising fresh capital for subsidiary investment, debt repayment and corporate requirements.

The company has an established presence in specialty chemicals and a business centered around unsaturated polyester resins. Its proposed expansion at Asoda, Haryana, along with investment in Croda Pigments, could provide additional growth opportunities.

However, investors should not look at the GMP alone. The company's FY2025 PAT declined despite higher sales, while product concentration, raw-material prices, environmental compliance and expansion execution remain important risks.

The IPO closes today, September 11, 2026, with allotment scheduled for September 15 and the BSE SME listing expected on September 17.

For investors evaluating the issue, the combination of subscription demand, current GMP, valuation, financial performance and future capacity expansion provides a more balanced way to assess the Amtech Esters IPO.

Disclaimer: Grey Market Premium is unofficial and can change at any time. GMP-based listing estimates are not guaranteed. IPO information is provided for informational purposes only and should not be considered investment advice.